Systemic metabolic alterations associated with repeated injections of a modified polyriboinosinic-polyribocytidylic acid complex
- PMID: 921256
- PMCID: PMC429983
- DOI: 10.1128/AAC.12.5.602
Systemic metabolic alterations associated with repeated injections of a modified polyriboinosinic-polyribocytidylic acid complex
Abstract
Polyriboinosinic acid-polyribocytidylic acid complexed with poly-1-lysine and injected intramuscularly into rats (0.3 or 3.0 mg/kg) produced fever, altered leukocyte count, slightly depressed plasma zinc, increased amino acid uptake into liver, and increased plasma acute-phase globulins two- to threefold. It is suggested that these systemic metabolic alterations are indicative of a mild inflammatory response to this drug. The metabolic alterations may have to be taken into consideration when polyriboinosinic acid-polyribocytidylic acid complexed with poly-1-lysine is used in therapy.
Similar articles
-
Modified polyriboinosinic-polyribocytidylic acid complex: induction of serum interferon, fever, and hypotension in rabbits.Antimicrob Agents Chemother. 1980 Jan;17(1):49-54. doi: 10.1128/AAC.17.1.49. Antimicrob Agents Chemother. 1980. PMID: 7352750 Free PMC article.
-
Interferon induction in primates by stabilized polyriboinosinic acid-polyribocytidylic acid: effect of component size.Infect Immun. 1981 Nov;34(2):416-21. doi: 10.1128/iai.34.2.416-421.1981. Infect Immun. 1981. PMID: 6171519 Free PMC article.
-
Interferon induction in cynomolgus and rhesus monkey after repeated doses of a modified polyriboinosinic-polyribocytidylic acid complex.Antimicrob Agents Chemother. 1977 Jan;11(1):80-3. doi: 10.1128/AAC.11.1.80. Antimicrob Agents Chemother. 1977. PMID: 402107 Free PMC article.
-
Modified polyriboinosinic-polyribocytidylic acid complex: modulation of toxicity for rabbits by alterations in components.Antimicrob Agents Chemother. 1980 Sep;18(3):409-15. doi: 10.1128/AAC.18.3.409. Antimicrob Agents Chemother. 1980. PMID: 6158914 Free PMC article.
-
Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant.Adv Drug Deliv Rev. 2013 Oct;65(10):1386-99. doi: 10.1016/j.addr.2013.05.013. Epub 2013 Jun 7. Adv Drug Deliv Rev. 2013. PMID: 23751781 Review.
Cited by
-
A brief, highly selective history of acute phase proteins as indicators of infection, inflammation and injury.Inflammopharmacology. 2021 Jun;29(3):897-901. doi: 10.1007/s10787-021-00820-z. Epub 2021 May 21. Inflammopharmacology. 2021. PMID: 34019218 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources